# AI-Driven Biosimulation for Drug Discovery

Netabolics is a biotech company developing a platform for combinational drug repurposing in **precision oncology**. 

Our [patented](https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022162440) technology integrates multi-Omics data, ordinary differential equations (ODE)-based genome-scale simulation, and deep reinforcement learning (DRL)-based drug target deconvolution to develop combination therapies sensitive to cancer diversity.